Journal of the National Cancer Center (Sep 2021)
Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women
- Fei Ma,
- Jiong Wu,
- Li Fu,
- Anhua Li,
- Bo Lan,
- Kexin Chen,
- Jiangli Di,
- Yuxin Jiang,
- Jing Li,
- Ni Li,
- Yexiong Li,
- Peifang Liu,
- Jinsong Lu,
- Lijuan Niu,
- Weijun Peng,
- Songjie Shen,
- Jufang Shi,
- Qiang Sun,
- Zhongsheng Tong,
- Jing Wang,
- Yong Wang,
- Shusen Wang,
- Yuntao Xie,
- Jianming Ying,
- Jin Zhang,
- Kai Zhang,
- Zhihui Zhang,
- Ying Zheng,
- Qingli Zhu,
- Binghe Xu
Affiliations
- Fei Ma
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding authors.
- Jiong Wu
- Fudan University Shanghai Cancer Centre, Shanghai, China
- Li Fu
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Anhua Li
- Sun Yat-sen University Cancer Center, Guangzhou, China
- Bo Lan
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Kexin Chen
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Jiangli Di
- Chinese Center For Disease Control And Prevention, Beijing, China
- Yuxin Jiang
- Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
- Jing Li
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Ni Li
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yexiong Li
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Peifang Liu
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Jinsong Lu
- Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Lijuan Niu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Weijun Peng
- Fudan University Shanghai Cancer Centre, Shanghai, China
- Songjie Shen
- Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
- Jufang Shi
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Qiang Sun
- Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
- Zhongsheng Tong
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Jing Wang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yong Wang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Shusen Wang
- Sun Yat-sen University Cancer Center, Guangzhou, China
- Yuntao Xie
- Peking University Cancer Hospital and Institute, Beijing, China
- Jianming Ying
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Jin Zhang
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Kai Zhang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Zhihui Zhang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Ying Zheng
- Fudan University Shanghai Cancer Centre, Shanghai, China
- Qingli Zhu
- Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
- Binghe Xu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding authors.
- Journal volume & issue
-
Vol. 1,
no. 3
pp. 97 – 100
Abstract
Breast cancer has become the most common malignant tumor worldwide. However, the survival rate of breast cancer patients in China is 8% lower compared to that in European and American countries. Insufficient screening coverage and low rate of early detection are key problems. Therefore, it is imperative to develop a set of guidelines for breast cancer screening, early diagnosis, and treatment strategies suitable for Chinese women. The National Health Commission, the National Cancer Center, and the National Cancer Quality Control Center collectively organized a committee of specialists with multidisciplinary backgrounds in breast surgery, oncology, radiotherapy, diagnostic imaging, ultrasound, pathology, epidemiology, and health economics. The committee collectively published ''China Breast Cancer Screening, Early Diagnosis and Treatment Specification'', in which the committee outlined a set of strategies of breast cancer screening, early diagnosis, and treatment suitable for China's national conditions. The strategies were formulated based on clinical experience in breast cancer prevention and treatment, characteristics of breast cancer patients in China, and socioeconomic conditions. The purpose of this article is to provide an interpretation of the above guidelines as a reference for breast cancer screening.
